Indraprastha Medical [INDRAMEDCO] vs Unichem Laboratories [UNICHEMLAB] Detailed Stock Comparison

Indraprastha Medical Corporation Ltd.

NSE
Loading...

Unichem Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Indraprastha Medical Corporation Ltd. wins in 9 metrics, Unichem Laboratories Ltd. wins in 10 metrics, with 0 ties. Unichem Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Indraprastha Medical Corporation Ltd. Unichem Laboratories Ltd. Better
P/E Ratio (TTM) 20.08 8.91 Unichem Laboratories Ltd.
Price-to-Book Ratio 5.57 1.08 Unichem Laboratories Ltd.
Debt-to-Equity Ratio 4.76 20.62 Indraprastha Medical Corporation Ltd.
PEG Ratio -5.81 0.02 Unichem Laboratories Ltd.
EV/EBITDA 12.10 14.37 Indraprastha Medical Corporation Ltd.
Profit Margin (TTM) 12.60% 13.32% Unichem Laboratories Ltd.
Operating Margin (TTM) 13.64% 2.60% Indraprastha Medical Corporation Ltd.
EBITDA Margin (TTM) 13.64% 2.60% Indraprastha Medical Corporation Ltd.
Return on Equity 26.98% 5.61% Indraprastha Medical Corporation Ltd.
Return on Assets (TTM) 18.90% 3.85% Indraprastha Medical Corporation Ltd.
Free Cash Flow (TTM) $1.20B $-1.44B Indraprastha Medical Corporation Ltd.
Dividend Yield 0.95% N/A N/A
1-Year Return -5.84% -26.15% Indraprastha Medical Corporation Ltd.
Price-to-Sales Ratio (TTM) 2.53 1.18 Unichem Laboratories Ltd.
Enterprise Value $32.43B $30.22B Indraprastha Medical Corporation Ltd.
EV/Revenue Ratio 2.23 1.37 Unichem Laboratories Ltd.
Gross Profit Margin (TTM) 37.00% 54.51% Unichem Laboratories Ltd.
Revenue per Share (TTM) $158 $314 Unichem Laboratories Ltd.
Earnings per Share (Diluted) $19.94 $41.78 Unichem Laboratories Ltd.
Beta (Stock Volatility) 0.58 -0.21 Unichem Laboratories Ltd.

Indraprastha Medical Corporation Ltd. vs Unichem Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

INDRAMEDCO
UNICHEMLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Indraprastha Medical Corporation Ltd.0.38%-0.95%4.95%-1.44%-21.11%-14.34%
Unichem Laboratories Ltd.-1.71%23.27%18.14%42.52%-5.28%0.01%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Indraprastha Medical Corporation Ltd.-5.84%323.69%338.93%635.89%971.03%1,203.39%
Unichem Laboratories Ltd.-26.15%21.24%39.74%72.55%182.75%381.29%

Performance & Financial Health Analysis: Indraprastha Medical Corporation Ltd. vs Unichem Laboratories Ltd.

MetricINDRAMEDCOUNICHEMLAB
Market Information
Market Cap i₹37.31B₹26.22B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i399,15363,709
90 Day Avg. Volume i289,58356,616
Last Close₹385.95₹439.95
52 Week Range₹342.00 - ₹640.85₹278.20 - ₹657.95
% from 52W High-39.78%-33.13%
All-Time High₹640.85 (Nov 06, 2025)₹937.95 (Nov 04, 2024)
% from All-Time High-39.78%-53.09%
Growth Metrics
Quarterly Revenue Growth0.14%-0.02%
Quarterly Earnings Growth0.25%3.57%
Financial Health
Profit Margin (TTM) i0.13%0.13%
Operating Margin (TTM) i0.14%0.03%
Return on Equity (TTM) i0.27%0.06%
Debt to Equity (MRQ) i4.7620.62
Cash & Liquidity
Book Value per Share (MRQ)₹71.88₹346.08
Cash per Share (MRQ)₹50.31₹27.48
Operating Cash Flow (TTM) i₹1.78B₹-1,166,300,000
Levered Free Cash Flow (TTM) i₹1.61B₹1.38B
Dividends
Last 12-Month Dividend Yield i0.95%N/A
Last 12-Month Dividend i₹4.50₹0.00

Valuation & Enterprise Metrics Analysis: Indraprastha Medical Corporation Ltd. vs Unichem Laboratories Ltd.

MetricINDRAMEDCO (Apr 24, 2026)UNICHEMLAB (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i20.088.91
Forward P/E i18.63N/A
PEG Ratio i-5.810.02
Price to Sales (TTM) i2.531.18
Price to Book (MRQ) i5.571.08
Market Capitalization
Market Capitalization i₹37.31B₹26.22B
Enterprise Value i₹32.43B₹30.22B
Enterprise Value Metrics
Enterprise to Revenue i2.231.37
Enterprise to EBITDA i12.1014.37
Risk & Other Metrics
Beta i0.58-0.21
Book Value per Share (MRQ) i₹71.88₹346.08

Financial Statements Comparison: Indraprastha Medical Corporation Ltd. vs Unichem Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricINDRAMEDCO (2025)UNICHEMLAB (2025)
Revenue/Sales i13.07B20.64B
Cost of Goods Sold i8.53B9.95B
COGS % of Revenue i65.3%48.2%
Gross Profit i4.54B10.69B
Gross Margin i34.7%51.8%
Research & Development iN/A185.10M
Operating Income (EBIT) i2.10B1.40B
Operating Margin i16.1%6.8%
EBITDA i2.64B2.90B
EBITDA Margin i20.2%14.0%
Pre-Tax Income i2.16B1.55B
Pre-Tax Income % of Revenue i16.6%7.5%
Income Tax i553.30M170.70M
Income Tax % of Revenue i4.2%0.8%
Net Income (Profit) i1.61B1.38B
Profit Margin i12.3%6.7%

Balance Sheet & Liquidity Metrics

MetricINDRAMEDCO (2025)UNICHEMLAB (2025)
Cash & Equivalents i614.80M895.80M
Total Current Assets i4.31B20.29B
Total Current Assets % of Revenue i33.0%98.3%
Total Current Liabilities i1.79B9.92B
Total Current Liabilities % of Revenue i13.7%48.0%
Long-Term Debt i305.40M860.00M
Long-Term Debt % of Revenue i2.3%4.2%
Total Shareholders Equity i5.97B24.51B
Retained Earnings i4.75B24.56B
Retained Earnings % of Revenue i36.4%119.0%
Property, Plant & Equipment i2.60B12.79B

Cash Flow Statement Comparison

MetricINDRAMEDCO (2025)UNICHEMLAB (2025)
Operating Cash Flow i1.78B-1.17B
Operating Cash Flow % of Revenue i13.6%-5.6%
Capital Expenditures i-363.30M-1.35B
Free Cash Flow i1.20B-1.44B
FCF Margin i9.2%-7.0%
Debt Repayment iN/A-256.60M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricINDRAMEDCOUNICHEMLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i91.67M70.41M
Float Shares i41.01M20.06M
% Held by Insiders i55.41%71.31%
% Held by Institutions i0.57%10.05%
% Held by Public i44.02%18.64%

Dividend Analysis & Yield Comparison: Indraprastha Medical Corporation Ltd. vs Unichem Laboratories Ltd.

MetricINDRAMEDCOUNICHEMLAB
Last 12-Month Dividend i₹4.50₹0.00
Last 12-Month Dividend Yield i0.95%N/A
3-Year Avg Annual Dividend i₹4.00₹1.33
3-Year Avg Dividend Yield i1.26%1.34%
3-Year Total Dividends i₹12.00₹4.00
Ex-Dividend DateSep 18, 2025Aug 01, 2022